
About us
Talaria Inc., former Gaea APAC Inc., previously known as Gaea APAC Inc.
(a proud member of Gaea OU), restructured and revitalized its teams in 2024 to offer services specifically tailored for clinical trials and regulatory affairs in Asia Pacific client.
Talaria (탈라리아)는 가이아에이펙은 아시아 고객들의 특별한 요구충족을 만족시켜 드리기 위해서
2024년 새롭게 신약 ・ 의료기기 개발에 있어서 고객 맞춤 서비스를 런칭하였습니다.
에르메스의 날개달린 샌들인 Talaria 처럼 언제 어디서든 빠르고 정확하게 Talria만의 특화된 서비스를 만나 보세요

Our Purpose
Talaria, We believe that access to qualified healthcare and medicine should be a fundamental right for all.
Our commitment is to ensure that no one is left behind, providing support and services that cater to your needs, wherever you are.
Together, we can build a healthier future for everyone.
Bringing healthcare closer to
everyone, every day, everywhere...
Chasing medical miracle
saving lives
what makes difference?
We are looking for forward-thinking solutions and the latest advancements in clinical research that a rapidly changing tech ear.
Trust can reassure clients and stakeholders that the company is committed to maintaining high standards and delivering trustworthy outcomes.
Innovation
New ideas, therapeutic methods, or products in the context of clinical trials, We highlights the client's commitment to advancing medical research and developing cutting-edge treatments.
Trust
Trust signifies reliability, integrity, and confidence. For a client, it underscores the importance of ethical practices, accurate results, and dependable partnerships.
Efficiency
Efficiency refers to achieving maximum productivity with minimum wasted effort or expense. In clinical trials, it means conducting studies in a timely and cost-effective manner without compromising quality.
History

2025 - Current
expend and growth
Expend new service areas to meet the newest medical device regulation
establishment of medical device Usability test centre which support Korean manufactures to expend global market
2024
Talaria renamed
Rename and service as Talaria
Reorganized team for full service Clinical Research
2022-2023
growth of business
involve gorvenment service
Dr. Charles JH Kim, CEO was appointed a reviewer and member of Korea Institute of Drug Safety and Risk Management (KIDS) and Medical Device Consulting Council (MDCC) at Korea Health Industry Development Institute (KHIDI)
2021
establishment of Gaea APAC Inc.
Full service CRO named Gaea APAC Inc. established on May 2021, a proud member of Gaea OU (EU based).
Talaria services
From Laboratory To clinic
Talaria provides a comprehensive array of tailored services designed to assist pharmaceutical, biotech, and medical device companies in accelerating the journey from laboratory to clinical market approval for new drugs and devices

Consulting
Talaria's consulting service provides strategic analysis to support and conduct best solution in drug and device development
Safety Solutions
Safety and adverse event causality assessment with Talaria's own safety assessment system (Korea Patent 10-2507211)
Clinical Operations
Talaria provides a range of integrated service that cover the feasibility, CTC approval, project management and execution and analysis of clinical trial
Patient care service
After clinical ends, patients who need
IMP (or ID) treatment of disease.
We can provide and assisst Compassionate Use (or Expanded Access Program) in Korea
Site ・ Investigator
Feasibility
Talaria understands that a key role in a successful clinical trial is finding the best doctors and hospitals. We take pride in our strong relationships with top investigators, ensuring that you have access to the best professionals for your clinical trial. Trust us to connect you with the right doctors who will help you achieve your goals effectively. Let us support you in making your clinical trial a success.

Contact Us

Address
2F 21, Tehelan road 128,
Gangnam gu, Seoul, Korea
Opening Hours
Mon - Fri: 9am - 6pm
Saturday / Sunday: Closed
National holiday: Closed
Contact
+82-70 4506 9110
info@talaria.im